These junior ASX companies are keen to unlock the rich mineral bounty in the Northern Territory’s largely underexplored ground.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Optiscan has made key progress in the December quarter with multiple clinical studies advancing to support US FDA submissions planned for 2026.
After a busy December quarter and a refreshed DFS, analysts see Ausgold as well placed for a re-rate as it edges closer to development at Katanning.
Pioneer Minerals CEO Michael Beven joins Tylah Tully to explore North America’s growing critical minerals demand and how the company is positioning across tungsten, uranium and lithium.
